Clinical Trials Browser

Terminated × Squamous Cell Carcinoma of Head and Neck × ribociclib × Clear all

NCT04000529 2025-09-30

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Phase 1 Terminated

GastrointestinalHead & NeckSarcomaThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT02429089 2020-01-09

CETLEE011

Phase 1 Terminated

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT03179956 2019-02-25

Impact of Ribociclib on Head and Neck Squamous Cell Cancer

Phase EARLY_PHASE1 Terminated

Squamous Cell Carcinoma of Head and Neck